PEEP-HUPA: Pilot Study of Positive-End Expiratory Pressure in Acute Respiratory Distress Syndrome

Sponsor
Hospital Universitario Principe de Asturias (Other)
Overall Status
Completed
CT.gov ID
NCT01119872
Collaborator
(none)
70
1
2
71
1

Study Details

Study Description

Brief Summary

Randomized controlled pilot trial in 70 patients with Acute Respiratory Distress Syndrome (ARDS) ventilated with low tidal volumes and limitation on airway pressure at 35 centimeters of water (cmH2O), to compare two different methods of selecting the level of Positive End-Expiratory Pressure (PEEP) to be applied: according to fraction of inspired oxygen (FiO2) needed or individualized according to the best compliance. Primary objective was evolution of arterial oxygenation during the 28 days. Secondary objectives were to measure its effects on hemodynamic parameters, 28-day mortality, number of ventilator-free days at day 28, Intensive Care Unit (ICU) and hospital stay, number of multiple-organ dysfunction-free days and a multivariate analysis of 28 day-mortality.

Condition or Disease Intervention/Treatment Phase
  • Other: Positive End-expiratory Pressure (PEEP)
N/A

Detailed Description

In patients with Acute Respiratory Distress Syndrome the use of Positive End-Expiratory Pressure (PEEP) avoids atelectrauma, improves gas exchange and induces alveolar recruitment.Although it has side effects as inducing alveolar overdistension and circulatory depression.

There are several methods to determine the level of PEEP to be applied. We conducted a study to test the hypothesis that an individualized level of PEEP, set et the best compliance, when compared with a fixed level according to the fraction of inspired oxygen applied, improves oxygenation and reduces mortality rate at 28 days.

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized Controlled Pilot Study of Positive End-Expiratory Pressure (PEEP) in Acute Respiratory Distress Syndrome(ARDS): Individualized According to the Best Compliance or Fixed According to Fraction of Inspired Oxygen (FiO2) Applied
Study Start Date :
Jan 1, 2003
Actual Primary Completion Date :
Dec 1, 2007
Actual Study Completion Date :
Dec 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Other: Compliance-guided PEEP group

Positive End-Expiratory Pressure(PEEP) level was set daily, according to the method described by Suter in 1978. Static compliance (Cst) was calculated at different levels of PEEP at a constant tidal ventilation of 6-8 ml/kg of predicted body weight. Cst was determined by dividing tidal volume by the difference between the pressure at the end of inflation hold and the PEEP. The maximum value of Cst in individual patients was considered as the best PEEP.

Other: Positive End-expiratory Pressure (PEEP)
All patients were ventilated during 24 hours with low tidal volume (6-8 milliliters/kilogram of predicted body weight), plateau airway pressure limited at 35 centimeters of water, initial ventilator rate of 30 breaths/minute adjusted to maintain a pH goal of 7.30 to 7.45 to a maximum of 35 breaths/minute, fraction of inspired oxygen ensuring arterial oxygen saturation 88-95% or arterial partial pressure of oxygen of 55-80 mmHg. Level of Positive End-Expiratory Pressure (PEEP) applied according the 2 arms of treatment.
Other Names:
  • Compliance-guided PEEP group: Grupo meseta
  • FiO2-driven-PEEP group: Grupo tabla
  • Other: FiO2-driven-PEEP group

    PEEP was set based on the patient fraction of inspired oxygen (FiO2) according to the Positive End-Expiratory Pressure(PEEP) strategy reported in 2000:"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network".

    Other: Positive End-expiratory Pressure (PEEP)
    All patients were ventilated during 24 hours with low tidal volume (6-8 milliliters/kilogram of predicted body weight), plateau airway pressure limited at 35 centimeters of water, initial ventilator rate of 30 breaths/minute adjusted to maintain a pH goal of 7.30 to 7.45 to a maximum of 35 breaths/minute, fraction of inspired oxygen ensuring arterial oxygen saturation 88-95% or arterial partial pressure of oxygen of 55-80 mmHg. Level of Positive End-Expiratory Pressure (PEEP) applied according the 2 arms of treatment.
    Other Names:
  • Compliance-guided PEEP group: Grupo meseta
  • FiO2-driven-PEEP group: Grupo tabla
  • Outcome Measures

    Primary Outcome Measures

    1. Arterial Oxygenation [28 days]

      Evolution of arterial oxygenation during the 28 days after study randomization

    Secondary Outcome Measures

    1. Mortality [28 days]

      Mortality 28 days after randomization

    2. Number of ventilator-free days at day 28 [28 days]

      Number of ventilator-free days at day 28 after randomization

    3. multivariate analysis of mortality [28 days]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with Acute Respiratory Distress Syndrome (ARDS) according to the American-European Consensus Conference definition, after 24 hours under mechanical ventilation.
    Exclusion Criteria:
    • Younger than 18-year-old

    • Pregnancy

    • Neuromuscular diseases

    • Intracranial hypertension. Head trauma

    • Left ventricular dysfunction

    • Mechanical ventilation for more than 72 hours

    • Previous barotrauma

    • Patients with terminal stage of an illness and high risk of mortality within 90 days

    • Patients who refused to consent to the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Critical Care Unit. Universitary Hospital Principe de Asturias Alcalá de Henares Madrid Spain 28805

    Sponsors and Collaborators

    • Hospital Universitario Principe de Asturias

    Investigators

    • Principal Investigator: María del Consuelo Pintado, MD, PhD, Critical Care Unit. Universitary Hospital Principe de Asturias
    • Principal Investigator: Raúl de Pablo, MD, PhD, Critical Care Unit. Universitary Hospital Principe de Asturias

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01119872
    Other Study ID Numbers:
    • UCI-HUPA-1
    First Posted:
    May 10, 2010
    Last Update Posted:
    May 10, 2010
    Last Verified:
    Dec 1, 2002

    Study Results

    No Results Posted as of May 10, 2010